TMO

2025Q2BMO

Thermo Fisher Scientific Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2025-07-23 · Fiscal end 2025-06-30 · Features as of 2025-07-22

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS5.23
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.0%
IV front—
P/C full—
P/C front—
Features as of2025-07-22

Run-up

Close—
Ret 5d+2.3%
Ret 10d+0.3%
Ret 20d+6.8%
Ret 30d+6.4%

Post-Earnings Data

Results & reaction

Print

Actual EPS
5.36Beat
Estimated EPS5.23
Actual revenue
10.9B
Surprise %+2.5%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction-1.4%
Implied vs actual

Implied 2.0%Actual 10.7%

Gap reaction+10.7%
Day result+9.1%
Next-day upNo
Realized / IV5.29×

Post tape

Post 5d+2.3%
Post 10d-3.8%
Post volume8.9M
Vol ×10d3.26×
Vol ×20d3.24×
Post range4.7%